Form D · Biotechnology
Ignyta, Inc.
San Diego, CA · CIK 0001557421
Offering snapshot reported Nov 16, 2015 · SEC filing
- Reported sold
- $30M Offering amount: $39M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2015 | Initial | $30,000,000 | No comparison | 1 | SEC filing |
| Dec 9, 2013 | Initial | $7,620,576 | No comparison | 195 | SEC filing |
| Nov 12, 2013 | Initial | $29,498,814 | No comparison | 27 | SEC filing |
| Nov 12, 2013 | Initial | $46,440,852 | No comparison | 52 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-251326
Source: Form D, filed Nov 16, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Igor P. Bilinsky, Ph.D. | Executive |
| James Bristol, Ph.D. | Director |
| Alex Casdin | Director |
| Alexander Casdin | Director |
| Jacob Chacko, M.D. | Executive |
| Heinrich Dreismann | Director |
| Heiner Dreismann, Ph.D. | Director |
| James Freddo, M.D. | Director |
| Valerie Harding, Ph.D. | Executive |
| Zachary Hornby | Executive |
| Jonathan Lim | Director, Executive |
| Jonathan E. Lim, M.D. | Director, Executive |
| Pratik S. Multani, M.D. | Executive |
| Patrick O'connor | Executive |
| Matt Onaitis, J.D. | Executive |
| Bernard Parker | Executive |
| Robert Wild, Ph.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11111 Flintkote Ave.
San Diego, CA, 92121
San Diego, CA, 92121